Digital PCR Assays for Precise Quantification of CD19-CAR-T Cells after Treatment with Axicabtagene Ciloleucel

June, 2018, Chimeric Antigen Receptor Therapy, N. Engl. J. Med., 379, 64, 10.1056/NEJMra1706169

Chow, 2018, Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma, Blood, 132, 777, 10.1182/blood-2018-04-839217

Neelapu, 2017, Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma, N. Engl. J. Med., 377, 2531, 10.1056/NEJMoa1707447

Locke, 2019, Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial, Lancet Oncol., 20, 31, 10.1016/S1470-2045(18)30864-7

Sykes, 1992, Quantitation of targets for PCR by use of limiting dilution, Biotechniques, 13, 444

Vogelstein, 1999, Digital PCR, Proc. Natl. Acad. Sci. USA, 96, 9236, 10.1073/pnas.96.16.9236

Stahl, 2015, Digital PCR to assess hematopoietic chimerism after allogeneic stem cell transplantation, Exp. Hematol., 43, 462, 10.1016/j.exphem.2015.02.006

Della Starza, 2019, Minimal Residual Disease in Acute Lymphoblastic Leukemia: Technical and Clinical Advances, Front. Oncol., 9, 726, 10.3389/fonc.2019.00726

Mock, 2016, Digital PCR to assess gene-editing frequencies (GEF-dPCR) mediated by designer nucleases, Nat. Protoc., 11, 598, 10.1038/nprot.2016.027

Fehse, 2001, Real-time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation, J. Hematother. Stem Cell Res., 10, 419, 10.1089/152581601750289028

Fehse, 2004, Pois(s)on—it’s a question of dose., Gene Ther., 11, 879, 10.1038/sj.gt.3302270

Locke, 2017, Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma, Mol. Ther., 25, 285, 10.1016/j.ymthe.2016.10.020

Kochenderfer, 2009, Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor, J. Immunother., 32, 689, 10.1097/CJI.0b013e3181ac6138

Lee, 2019, ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells, Biol. Blood Marrow Transplant., 25, 625, 10.1016/j.bbmt.2018.12.758